A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis

REFERENCES

• Morrisroe K, Frech T, Schniering J, Maurer B, Nikpour M. Systemic sclerosis: The need for structured care. Best Pract Res Clin Rheumatol. 2016;30(1):3–21. doi:10.1016/j.berh.2016.04.004.
   PubMed Web of Science ®Google Scholar
• Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003. doi:10.1056/NEJMra0806188.
   PubMed Web of Science ®Google Scholar
• Chora I, Guiducci S, Manetti M, et al. Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis. Autoimmun Rev. 2015;14(4):314–322. doi:10.1016/j.autrev.2014.12.001.
   PubMed Web of Science ®Google Scholar
• Waszczykowska A, Gos R, Waszczykowska E, Dziankowska-Bartkowiak B, Jurowski P. Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci. 2013;9(6):1107–1113. doi:10.5114/aoms.2013.39217.
   PubMed Web of Science ®Google Scholar
• Horan EC. Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthalmol. 1969;53(6):388–392. doi:10.1136/bjo.53.6.388.
   PubMed Web of Science ®Google Scholar
• West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Ophthalmol. 1979;63(12):845–847. doi:10.1136/bjo.63.12.845.
   PubMed Web of Science ®Google Scholar
• Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40(2):78–83. doi:10.1007/s12016-010-8198-y.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of rheumatology/European league against rheumatism classification criteria for primary sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35–45. doi:10.1002/art.39859.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford). 2006;45(Suppl 4):iv43–46. doi:10.1093/rheumatology/kel310.
   PubMedGoogle Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
   PubMed Web of Science ®Google Scholar
• Tsubota K. Short tear film breakup time-type dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES64–DES70. doi:10.1167/iovs.17-23746.
   PubMed Web of Science ®Google Scholar
• Schirmer O. Studien zur Phisiology und Pathologie der Tranenabsonderung und Tranenab fuhr. Graefes Arch Clin Exp Ophthalmol. 1903;56:197–291. doi:10.1007/BF01946264.
   Google Scholar
• Jutley G, Carpenter D, Hau S, et al. Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment. Eye (Lond). 2016;30(10):1351–1358. doi:10.1038/eye.2016.128.
   PubMed Web of Science ®Google Scholar
• Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–1339. doi:10.1136/annrheumdis-2016-209909.
   PubMed Web of Science ®Google Scholar
• Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11–18. doi:10.5301/jsrd.5000231.
   PubMed Web of Science ®Google Scholar
• Van Den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–2747. doi:10.1002/art.38098.
   PubMed Web of Science ®Google Scholar
• Freire M, Rivera A, Sopeña B, et al. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review. Clin Exp Rheumatol. 2017;35(Suppl 106(4)):89–97.
   PubMed Web of Science ®Google Scholar
• Gomes Bde A, Santhiago MR, Magalhães P, Kara-Junior N, Azevedo MN, Moraes HV Jr. Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 2011;66(3):379–385. doi:10.1590/s1807-59322011000300003.
   PubMed Web of Science ®Google Scholar
• Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012;24(2):165–170. doi:10.1097/BOR.0b013e32834ff2e8.
   PubMed Web of Science ®Google Scholar
• Tailor R, Gupta A, Herrick A, Kwartz J. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54(2):292–304. doi:10.1016/j.survophthal.2008.12.007.
   PubMed Web of Science ®Google Scholar
• Albert DM, Jakobiec FA. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, PA: W.B.Saunders Company; 2000:4589–4595.
   Google Scholar
• Coyle EF. Scleroderma of the cornea. Br J Ophthalmol. 1956;40(4):239–241. doi:10.1136/bjo.40.4.239.
   PubMedGoogle Scholar
• Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh). 1984;62:69–74.
   PubMed Web of Science ®Google Scholar
• Gomes Bde A, Santhiago MR, Kara-Junior N, Noé RA, de Azevedo MN, Moraes HV Jr. Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea. 2011;30(10):1125–1128. doi:10.1097/ICO.0b013e318206cac1.
   PubMed Web of Science ®Google Scholar
• Şahin M, Yüksel H, Şahin A, et al. Evaluation of the anterior segment parameters of the patients with scleroderma. Ocul Immunol Inflamm. 2017;25(2):233–238. doi:10.3109/09273948.2015.1115079.
   PubMed Web of Science ®Google Scholar
• Nagy A, Rentka A, Nemeth G, et al. Corneal manifestations of systemic sclerosis. Ocul Immunol Inflamm. 2018;1–10. doi:10.1080/09273948.2018.
   Web of Science ®Google Scholar
• Nemet AY, Vinker S, Bahar I, Kaiserman I. The association of keratoconus with immune disorders. Cornea. 2010;29(11):1261–1264. doi:10.1097/ICO.0b013e3181cb410b.
   PubMed Web of Science ®Google Scholar
• Anayol MA, Coşkun M, Raza S, Çağil N, Çakmak HB, Şimşek Ş. Keratoconus in a case with scleroderma: A rare coexistence. Turkiye Klinikleri J Ophthalmol. 2018;27(1):81–84. doi:10.5336/ophthal.2016-51693.
   Google Scholar
• Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP, Incidence A-S. Prevalence of keratoconus: A nationwide registration study. Am J Ophthalmol. 2017;175:169–172. doi:10.1016/j.ajo.2016.12.015.
   PubMed Web of Science ®Google Scholar
• Horie K, Nishi M, Sawa M, Mochizuki M. A case of peripheral corneal ulcer accompanied by progressive systemic sclerosis. Nippon Ganka Gakkai Zasshi. 1992;96:922–929.
   PubMedGoogle Scholar
• Sii F, Lee GA, Sanfilippo P, Stephensen DC. Pellucid marginal degeneration and scleroderma. Clin Exp Optom. 2004;87:180–184.
   PubMedGoogle Scholar
• Al-Husainy S, Deane J. Bilateral keratomalacia in a cachectic scleroderma patient. Eye. 1999;13(Pt4):586–588. doi:10.1038/eye.1999.145.
   PubMedGoogle Scholar
• Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy. Am J Epidemiol. 1983;118(2):206–212. doi:10.1093/oxfordjournals.aje.a113628.
   PubMed Web of Science ®Google Scholar
• Milston R, Madigan MC, Sebag J. Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol. 2016;61(2):211–227. doi:10.1016/j.survophthal.2015.11.008.
   PubMed Web of Science ®Google Scholar
• Agatston HJ. Scleroderma with retinopathy. Am J Ophthalmol. 1953;36:120–121.
   PubMedGoogle Scholar
• Allanore Y, Parc C, Monnet D, Brézin AP, Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis. 2004;63(10):1276–1278. doi:10.1136/ard.2003.013540.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Maeda M, Sawada A, et al. Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol. 1999;43(6):539–542.
   PubMed Web of Science ®Google Scholar
• Gomes BF, Souza R, Valadão T, Kara-Junior N, Moraes HV, Santhiago MR. Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis? Int Ophthalmol. 2018;38(1):251–256. doi:10.1007/s10792-017-0454-1.
   PubMed Web of Science ®Google Scholar
• de AF, Gomes B, Santhiago MR, de Azevedo MN, Moraes HV Jr. Evaluation of dry eye signs and symptoms in patients with systemic sclerosis. Graefes Arch Clin Exp Ophthalmol. 2012;250(7):1051–1056. doi:10.1007/s00417-012-1938-3.
   PubMed Web of Science ®Google Scholar
• Stucchi CA, Geiser JD. Eye manifestations of generalized scleroderma. Aspects in common with Sjogren’s Syndrome. Doc Ophthalmol. 1967;22:72–110.
   PubMedGoogle Scholar
• Rasker JJ, Jayson MI, Jones DE, et al. Sjögren’s syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol. 1990;19(1):57–65.
   PubMed Web of Science ®Google Scholar
• Wangkaew S, Kasitanon N, Sivasomboon C, Wichainun R, Sukitawut W, Louthrenoo W. Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol. 2006;24:213–221.
   PubMed Web of Science ®Google Scholar
• Schein OD, Muñoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124(6):723–728. doi:10.1016/s0002-9394(14)71688-5.
   PubMed Web of Science ®Google Scholar
• Rentka A, Nagy A, Harsfalvi J, et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. Rheumatol Int. 2017;37(11):1835–1845. doi:10.1007/s00296-017-3794-2.
   PubMed Web of Science ®Google Scholar
• Hou MC, Huang SC, Wang HM, Tseng CL, Lo LC, Chen YL. A computerized system of nail-fold capillaroscopy for dry eye disease diagnosis. Multidim Syst Sign Process. 2012;23:515–524. doi:10.1007/s11045-012-0177-4.
   Web of Science ®Google Scholar